InsidersTradesSigma
Total declarations
Company
▲ Purchases (20 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
20
Disclosed sells
0
T+90 hit rate
48%
T+90 mean return
+16.2%
Across 27 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Krogulski Kenneth, Director. Insider active across 1 company, notably Cumberland Pharmaceuticals INC. In total, 39 reports have been logged. Split: 20 buys · 0 sell. Total volume traded: €5k. Activity tracked since 17 March 2021. The latest transaction was disclosed on 1 May 2025 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations39 total
45 shares@ US$4.86Common StockSEC:0001628280-25-029856:0
Ideal exit: 26 Jan 2026 (T+270)
45 shares@ US$4.240.3% of flowCommon StockSEC:0001628280-25-024346:0
Ideal exit: 27 Dec 2025 (T+270)
47 shares@ US$5.540.5% of flowCommon StockSEC:0001628280-25-016741:0
Ideal exit: 28 Nov 2025 (T+270)
1,000 shares@ US$5.179.2% of flowCommon StockSEC:0001628280-25-013546:0
6,500 shares@ US$1.7120.0% of flowCommon StockSEC:0001628280-25-003183:0
415 shares@ US$1.331.0% of flowCommon StockSEC:0001628280-24-052603:0
Ideal exit: 29 Aug 2025 (T+270)
380 shares@ US$1.150.8% of flowCommon StockSEC:0001628280-24-050104:0
Ideal exit: 29 Jul 2025 (T+270)
309 shares@ US$1.270.7% of flowCommon StockSEC:0001628280-24-045328:0
Ideal exit: 28 Jun 2025 (T+270)
250 shares@ US$1.380.6% of flowCommon StockSEC:0001628280-24-042110:0
221 shares@ US$1.470.6% of flowCommon StockSEC:0001214659-24-016036:0
221 shares@ US$1.470.6% of flowCommon StockSEC:0001214659-24-013691:0
134 shares@ US$1.520.4% of flowCommon StockSEC:0001214659-24-011871:0
5,000 shares@ US$1.7115.4% of flowCommon StockSEC:0001214659-24-005226:0
379 shares@ US$1.691.1% of flowCommon StockSEC:0001214659-23-017030:0
66 shares@ US$1.730.2% of flowCommon StockSEC:0001214659-23-016097:0
280 shares@ US$1.851.0% of flowCommon StockSEC:0001214659-23-015351:0
280 shares@ US$2.241.2% of flowCommon StockSEC:0001214659-23-014538:0
280 shares@ US$1.891.0% of flowCommon StockSEC:0001214659-23-013552:0
280 shares@ US$2.031.0% of flowCommon StockSEC:0001214659-23-013092:0
325 shares@ US$1.712.1% of flowCommon StockSEC:0001214659-23-012446:0
325 shares@ US$1.671.0% of flowCommon StockSEC:0001214659-23-012224:0
5,000 shares@ US$1.9717.6% of flowCommon StockSEC:0001209191-23-021262:0
105 shares@ US$2.530.5% of flowCommon StockSEC:0001209191-22-062641:0
Ideal exit: 29 Jul 2023 (T+270)
105 shares@ US$2.330.5% of flowCommon StockSEC:0001209191-22-062649:0
Ideal exit: 28 Aug 2023 (T+270)
105 shares@ US$2.570.5% of flowCommon StockSEC:0001209191-22-057939:0
Ideal exit: 24 Jun 2023 (T+270)
25 of 39 declarations
About Krogulski Kenneth
Kenneth Krogulski is an executive at CUMBERLAND PHARMACEUTICALS INC.
